Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More | Frank Vinluan | 03/27/20 | National |
Shkreli’s Retrophin Makes Hostile Bid For CA-based Transcept | Ben Fidler | 09/18/13 | New York |
Merck Sleep Drug Hits Trial Goals, Raising Hopes for New Blockbuster | Arlene Weintraub | 06/13/12 | New York |
Under Generic Pressure, San Diego’s Somaxon Looks for New Options | Bruce V. Bigelow | 12/20/11 | National |
Somnus Seeks Buyer For Insomnia Drug that Treats Midnight Awakenings | Arlene Weintraub | 06/15/11 | New York |
Somaxon Raises $5M | Bruce V. Bigelow | 06/13/11 | San Diego |
FDA Approves Sunovion Schizophrenia Drug | Erin Kutz | 10/29/10 | Boston |
Isis Snags Glaxo Deal, Orexigen Heads to FDA, Cyntellect Pockets $3M & More San Diego Area Life Sciences News | Luke Timmerman | 04/01/10 | San Diego |
San Diego’s Somaxon Readies to Wake Up Market for New Sleeping Pill | Denise Gellene | 03/29/10 | San Diego |
FDA Approves Somaxon Insomnia Pill, Torrey Pines Investment Raises Funds, Innovation Economy Shows Signs of Life, & More San Diego Life Sciences News | Denise Gellene | 03/25/10 | San Diego |
Somaxon Shares Boom on FDA Approval for Insomnia Drug | Luke Timmerman | 03/18/10 | San Diego |
Somaxon Eagerly Awaits (Another) FDA Ruling on Insomnia Drug | Luke Timmerman | 03/17/10 | San Diego |
Zogenix Raises Cash for Headaches, Sleepless in Somaxon, Dow Chemical Spins Out Pfēnex, & More San Diego Life Sciences News | Bruce V. Bigelow | 12/10/09 | San Diego |
Somaxon Shares Tumble as Insomnia Drug Rejected by FDA | Luke Timmerman | 12/07/09 | San Diego |
Somaxon Renews its Insomnia Drug Application, Raises $6M | Bruce V. Bigelow | 07/07/09 | San Diego |
Arena Insomnia Pill Fails in Clinical Trial, Halts Development of Drug | Luke Timmerman | 12/09/08 | San Diego |
Arena Pharmaceuticals’ Sleeper Drug Aims To Help You Stay Asleep | Luke Timmerman | 11/26/08 | San Diego |